Abstract
Ethanol (alcohol) consumption can modify immune responses. Moderate ethanol use is associated with lower production of mediators of inflammation and has anti-inflammatory effect, while ethanol abuse and alcoholism are linked with augmentation of inflammatory responses. Ethanol exposure can result in functional alterations of macrophages and other cells of the innate immune system. These cells recognize microbial antigens through Toll-like receptors (TLRs). Molecular mechanisms underlying the inflammatory responses stimulated via TLRs involve activation of intracellular signaling pathways that include mitogen-activated protein kinases (MAPKs) and transcription factor NFκB. Growing evidence indicates that ethanol can affect these cellular events in a manner that depends on the organ or cell type and the pattern of ethanol administration (moderate or acute versus chronic).
Keywords: Ethanol, inflammation, cardiovascular disease, cytokines, toll-like receptors, MAPK
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Ethanol and Inflammation
Volume: 6 Issue: 4
Author(s): Joanna Goral
Affiliation:
Keywords: Ethanol, inflammation, cardiovascular disease, cytokines, toll-like receptors, MAPK
Abstract: Ethanol (alcohol) consumption can modify immune responses. Moderate ethanol use is associated with lower production of mediators of inflammation and has anti-inflammatory effect, while ethanol abuse and alcoholism are linked with augmentation of inflammatory responses. Ethanol exposure can result in functional alterations of macrophages and other cells of the innate immune system. These cells recognize microbial antigens through Toll-like receptors (TLRs). Molecular mechanisms underlying the inflammatory responses stimulated via TLRs involve activation of intracellular signaling pathways that include mitogen-activated protein kinases (MAPKs) and transcription factor NFκB. Growing evidence indicates that ethanol can affect these cellular events in a manner that depends on the organ or cell type and the pattern of ethanol administration (moderate or acute versus chronic).
Export Options
About this article
Cite this article as:
Goral Joanna, Ethanol and Inflammation, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2007; 6 (4) . https://dx.doi.org/10.2174/187152307783219970
DOI https://dx.doi.org/10.2174/187152307783219970 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Blood Pressure and Vascular Alterations with Growth in Childhood
Current Pharmaceutical Design Therapeutic Potential of Plant Extracts and Phytochemicals Against Brain Ischemia-Reperfusion Injury: A Review
The Natural Products Journal Mutations of Mitochondrial DNA in Atherosclerosis and Atherosclerosis-Related Diseases
Current Pharmaceutical Design Vasospastic Angina and Ca Channel Blockers
Current Hypertension Reviews Editorial (Thematic Issue: Advances in the Pharmacokinetics of Natural Bioactive Polyphenols)
Current Drug Metabolism Brain Inflammation, Cholesterol, and Glutamate as Interconnected Participants in the Pathology of Alzheimers Disease
Current Pharmaceutical Design Current and Future Prospective of a Versatile Moiety: Imidazole
Current Drug Targets EDITORIAL [Hot Topic: Biomarkers in Cardiovascular Disease (Guest Editor: Dimitris Tousoulis)]
Current Medicinal Chemistry Olive Oil and Haemostasis: Platelet Function, Thrombogenesis and Fibrinolysis
Current Pharmaceutical Design Fibrinolytic Actinokinase-A Short Review
Cardiovascular & Hematological Agents in Medicinal Chemistry Vitamin D and Cardiovascular Disease: A Novel Agent for Reducing Cardiovascular Risk?
Current Vascular Pharmacology The Role of Infections in the Pathogenesis of Autoimmune Diseases
Current Drug Targets - Inflammation & Allergy Infants and Children with Tachycardia: Natural History and Drug Administration
Current Pharmaceutical Design Gender Disparities on Access to Care and Coronary Disease Management
Current Pharmaceutical Design Myalgic Encephalomyelitis: Symptoms and Biomarkers
Current Neuropharmacology Editorial [Hot Topic: Efficient Strategies for Signalling Pathway Mining (Guest Editors: Qingfeng Chen & Baoshan Chen)]
Current Protein & Peptide Science Vascular Risk Factors and Alzheimer’s Disease Pathogenesis: Are Conventional Pharmacological Approaches Protective For Cognitive Decline Progression?
CNS & Neurological Disorders - Drug Targets Energy Metabolism in the Normal and in the Diabetic Heart
Current Pharmaceutical Design Reactive Oxygen Species in Myocardial Reperfusion Injury: From Physiopathology to Therapeutic Approaches
Current Pharmaceutical Biotechnology Potential Anticancer Agents. I. Synthesis of Isoxazole Moiety Containing Quinazoline Derivatives and Preliminarily in vitro Anticancer Activity
Anti-Cancer Agents in Medicinal Chemistry